Astrazeneca (AZN) Cash from Discontinued Operations (2009 - 2026)
Astrazeneca (AZN) posted Cash from Discontinued Operations of $2.87 billion for Q2 2026, down 15.4% from $3.39 billion a year earlier and down 14.7% from the prior quarter.
Powered by 
Analysis
Astrazeneca (AZN) Cash from Discontinued Operations (2009 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Cash from Discontinued Operations at Astrazeneca was $13.7 billion, up 2.3% year-over-year; for FY2025, it was $14.58 billion, up 22.9% from FY2024.
- Annual Cash from Discontinued Operations has increased for seven consecutive years, with a five-year compound annual growth rate of 24.9% (FY2020 to FY2025).
- In prior years, Astrazeneca's Cash from Discontinued Operations was $11.86 billion in FY2024 (+14.7%), $10.35 billion in FY2023 (+5.5%), $9.81 billion in FY2022 (+64.5%) and $5.96 billion in FY2021 (+24.3%).
- Quarterly Cash from Discontinued Operations has run from a low of $1.25 billion in Q2 2022 to a high of $5.13 billion in Q3 2025 over five years.
- On a year-over-year basis, Cash from Discontinued Operations has declined in each of the last three quarters, with growth averaging 11.1% over the last six quarters.
- The strongest year-over-year quarter for Cash from Discontinued Operations in the past five years was Q2 2024, with growth of 79.6%; the weakest was Q4 2021, with a decline of 21.1%.
- According to Business Quant data, Cash from Discontinued Operations for the three prior quarters was $3.36 billion (Q1 2026), $2.34 billion (Q4 2025) and $5.13 billion (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Discont. Ops (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | - |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | - |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | - |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | - |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 2.87 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | - |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | - |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | - |
| 10 | Vertex Pharmaceuticals | 127.87 Bn | 99.88 Bn | 2.84 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.87 Bn |
| Mar 31, 2026 | 3.36 Bn |
| Dec 31, 2025 | 2.34 Bn |
| Sep 30, 2025 | 5.13 Bn |
| Jun 30, 2025 | 3.39 Bn |
| Mar 31, 2025 | 3.71 Bn |
| Dec 31, 2024 | 2.91 Bn |
| Sep 30, 2024 | 3.38 Bn |
| Jun 30, 2024 | 3.09 Bn |
| Mar 31, 2024 | 2.49 Bn |
| Jun 30, 2023 | 1.72 Bn |
| Mar 31, 2023 | 3.13 Bn |
| Jun 30, 2022 | 1.25 Bn |
| Mar 31, 2022 | 3.23 Bn |
| Dec 31, 2021 | 1.42 Bn |
| Sep 30, 2021 | 1.72 Bn |
| Jun 30, 2021 | 892.00 Mn |
| Mar 31, 2021 | 1.93 Bn |
| Dec 31, 2020 | 1.80 Bn |
| Sep 30, 2020 | 1.82 Bn |
API Access
Astrazeneca Cash from Discontinued Operations API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-from-discontinued-operations&ticker=AZN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-from-discontinued-operations", "ticker": "AZN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-from-discontinued-operations&ticker=AZN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();